Could AI Make IBS Diets More Personal And Practical?

Personalised AI-guided diets show promise for making IBS nutrition more responsive to individual gut health needs.

Digestive symptoms can make everyday food choices difficult for people with irritable bowel syndrome (IBS). As understanding of the gut microbiome grows, personalized nutrition is gaining attention as a way to make dietary choices more suited to an individual’s digestive needs rather than relying on the same approach for everyone (1^✔ ✔Trusted Source
A Multicenter Randomized Controlled Trial of Microbiome-Based Artificial Intelligence-Assisted Personalized Diet vs Low-Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols Diet: A Novel Approach for the Management of Irritable Bowel Syndrome

Go to source

).
A trial published in The American Journal of Gastroenterology suggests that combining gut microbiome information (information about the types and balance of bacteria living in the gut) with artificial intelligence (AI) may help create more personalized dietary plans. The trial involved 121 adults with IBS who followed either an AI-assisted personalised diet or a low-fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) diet for six weeks. Both approaches improved several IBS-related measures, including symptoms and quality of life.

AI Personalised Diet For IBS Offers An Individual Approach

IBS can involve abdominal pain, bloating and altered bowel habits. The personalized approach used gut microbiome information with an AI model to recommend foods intended to influence the microbial community in the digestive tract.

Instead of applying the same dietary restrictions to everyone, the AI generated recommendations based on individual microbiome information. These recommendations were then incorporated into a menu plan with help from a dietitian.

Gut Microbiome Changes With AI Personalised Nutrition

The personalized diet was associated with changes in microbiome diversity. It also increased the abundance of Faecalibacterium prausnitzii, a bacterium discussed in the paper for its potential role in producing butyrate and supporting the gut lining.

IBS Symptoms Improved With Both Dietary Approaches

Both groups experienced improvements in abdominal pain, abdominal distension, bowel-habit dissatisfaction and the effect of IBS symptoms on daily life. Quality of life also improved with the personalised diet across the IBS subtypes examined.

However, the AI-assisted diet was not shown to be superior to the low-FODMAP diet for overall IBS symptom severity. The findings suggest that personalised nutrition may have value, but this trial does not support replacing established dietary approaches with AI-based nutrition.

What AI Personalised Nutrition Could Mean For Daily IBS Management

For someone who finds that certain foods repeatedly trigger bloating or abdominal discomfort, personalised dietary planning could eventually offer a more individualised way to approach food choices.

The findings may be relevant to everyday decisions such as:

• Identifying foods that may fit an individual’s dietary plan
• Moving beyond a uniform dietary approach for every person with IBS
• Considering the gut microbiome alongside symptoms when planning nutrition
• Using personalised recommendations as part of structured dietary guidance

Personalised Nutrition May Shape IBS Care

The authors wrote, “The artificial intelligence-assisted PD (personalized diet) emerges as a promising approach for comprehensive IBS management,” according to Varol Tunali and colleagues.

The findings support continued investigation of dietary approaches that consider individual characteristics and the gut microbiome. The authors also call for longer-term monitoring to understand how personalised diets affect symptoms, microbiome changes and wellbeing.

For people living with IBS, these findings offer a reason to view nutrition as an individual process rather than a one-size-fits-all rule. As personalized approaches are refined, dietary guidance may become more responsive to the needs of each person.

Reference:

1. A Multicenter Randomized Controlled Trial of Microbiome-Based Artificial Intelligence-Assisted Personalized Diet vs Low-Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols Diet: A Novel Approach for the Management of Irritable Bowel Syndrome – (https://www.ovid.com/jnls/ajg/fulltext/10.14309/ajg.0000000000002862~a-multicenter-randomized-controlled-trial-of)

Source-Medindia